Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.74 USD
Change Today -0.04 / -5.13%
Volume 95.2K
CLRX On Other Exchanges
As of 8:10 PM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

collabrx inc (CLRX) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/2/14 - $3.03
52 Week Low
12/23/14 - $0.51
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for COLLABRX INC (CLRX)

Related News

No related news articles were found.

collabrx inc (CLRX) Related Businessweek News

No Related Businessweek News Found

collabrx inc (CLRX) Details

CollabRx, Inc. provides cloud-based expert systems to inform healthcare decision-making. The company’s cloud-based expert systems provide clinical knowledge to institutions, physicians, researchers, and patients for genomics-based medicine in cancer. It offers CollabRx Therapy Finder, a series of cancer-specific Web-based system applications that are accessed by physicians and patients. The company was formerly known as Tegal Corporation and changed its name to CollabRx, Inc. in September 2012. CollabRx, Inc. was founded in 1972 and is headquartered in San Francisco, California.

15 Employees
Last Reported Date: 02/23/15
Founded in 1972

collabrx inc (CLRX) Top Compensated Officers

Chairman, Chief Executive Officer, President,...
Total Annual Compensation: $285.1K
Chair of The Editorial Advisory Board, Editor...
Total Annual Compensation: $139.4K
Chief Operating Officer and Vice President
Total Annual Compensation: $13.8K
Consultant and Director
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

collabrx inc (CLRX) Key Developments

Medytox Solutions, Inc. and CollabRx, Inc. Announces Executive Changes

Medytox Solutions, Inc. and CollabRx, Inc. announced that they have entered into a definitive merger agreement. Closing of the merger is subject to, among other things, gaining stockholder approvals from both companies, receipt of regulatory approvals and other customary closing conditions. Following the merger, Seamus Lagan will be CEO of the combined company. Thomas Mika and Dr. Paul Billings will be appointed to the combined company’s seven-member board, which will include the five current directors of Medytox. Mr. Mika will serve as Executive Chairman, as well as CEO of CollabRx, Inc., which will operate as a wholly-owned subsidiary of the combined companies.

CollabRx, Inc. Promotes Smruti J. Vidwans to Chief Science Officer

CollabRx, Inc. announced that Smruti J. Vidwans, PhD, currently the company's chief scientist, has been appointed chief science officer. Prior to joining CollabRx, Vidwans was at McKinsey and company where she worked on a developing a range of business and scientific solutions for the pharmaceutical industry.

Gavin Gordon to Resign from CollabRx, Inc. as Vice President Business Development and Strategic Alliances, Effective April 24, 2015

On April 2, 2015, Gavin Gordon announced CollabRx, Inc. that he will resign from his position of Vice President Business Development and Strategic Alliances, effective April 24, 2015. Following his resignation, Dr. Gordon will pursue new opportunities outside the company.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLRX:US $0.74 USD -0.04

CLRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CLRX.
View Industry Companies

Industry Analysis


Industry Average

Valuation CLRX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.5x
Price/Book 1.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 11.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact COLLABRX INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at